James Garner AKA JG, page-142

The problem here is even if the real value is $5 or $15....it's hard to extract that with the big Pharmas always trying to get in and take out the smaller companies once the trial is successful...

It's with all the companies...WES tried to take out LYC at $2.6 and it peaked at $11.00 ..

SQM has some interest in AZS for $2.30 and existing SP is higher.

Only way one would be saved from vultures is if the management is our side...
If the trial is sucessful then anything is possible...DMD inflammation is a huge market with no competition in advanced stage like us....it's a matter of getting those results next year...it's a make or break...

We can be easily be a billion $$ company in next 2 years.

Hence it's important to get this trial going at full pace..


Imo